Search icon

INTRA-CELLULAR THERAPIES, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: INTRA-CELLULAR THERAPIES, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 24 Jan 2014 (11 years ago)
Entity Number: 4518762
ZIP code: 10005
County: New York
Place of Formation: Delaware
Address: 28 LIBERTY STREET, NEW YORK, NY, United States, 10005
Principal Address: 430 East 29th Street, New York, NY, United States, 10016

Agent

Name Role Address
CT CORPORATION SYSTEM Agent 28 LIBERTY STREET, NEW YORK, NY, 10005

DOS Process Agent

Name Role Address
C/O CT CORPORATION SYSTEM DOS Process Agent 28 LIBERTY STREET, NEW YORK, NY, United States, 10005

Chief Executive Officer

Name Role Address
SHARON MATES Chief Executive Officer 430 EAST 29TH STREET, NEW YORK, NY, United States, 10016

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Phone Number:
E-mail Address:
Contact Person:
TWINKLE PATEL
Ownership and Self-Certifications:
Self-Certified Small Disadvantaged Business
User ID:
P0307230

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
3CQL3
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-04-18
CAGE Expiration:
2029-04-18
SAM Expiration:
2025-04-12

Contact Information

POC:
TWINKLE PATEL
Phone:
+1 929-542-8917

Form 5500 Series

Employer Identification Number (EIN):
300074620
Plan Year:
2012
Number Of Participants:
27
Sponsors Telephone Number:
Plan Year:
2011
Number Of Participants:
27
Sponsors Telephone Number:
Plan Year:
2010
Number Of Participants:
30
Sponsors Telephone Number:
Plan Year:
2009
Number Of Participants:
30
Sponsors Telephone Number:

History

Start date End date Type Value
2024-01-19 2024-01-19 Address 430 EAST 29TH STREET, SUITE 900, NEW YORK, NY, 10016, USA (Type of address: Chief Executive Officer)
2024-01-19 2024-01-19 Address 430 EAST 29TH STREET, NEW YORK, NY, 10016, USA (Type of address: Chief Executive Officer)
2020-02-27 2024-01-19 Address 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Registered Agent)
2020-02-27 2024-01-19 Address 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process)
2019-03-26 2024-01-19 Address 430 EAST 29TH STREET, SUITE 900, NEW YORK, NY, 10016, USA (Type of address: Chief Executive Officer)

Filings

Filing Number Date Filed Type Effective Date
240119002876 2024-01-19 BIENNIAL STATEMENT 2024-01-19
220105003304 2022-01-05 BIENNIAL STATEMENT 2022-01-05
200227000160 2020-02-27 CERTIFICATE OF CHANGE 2020-02-27
200121060156 2020-01-21 BIENNIAL STATEMENT 2020-01-01
190326060274 2019-03-26 BIENNIAL STATEMENT 2018-01-01

USAspending Awards / Contracts

Procurement Instrument Identifier:
36F79720D0229
Award Or Idv Flag:
IDV
Action Obligation:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2020-10-01
Description:
PRODUCT DELETION
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
36F79720D035E
Award Or Idv Flag:
IDV
Action Obligation:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2020-04-03
Description:
42-2A: LIFE CYCLE CHANGE AT PERMANENT FCP STAGE
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
W81XWH06C0013
Award Or Idv Flag:
AWARD
Award Type:
DCA
Action Obligation:
0.00
Base And Exercised Options Value:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2007-10-22
Description:
CHANGE COR
Naics Code:
541990: ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
Product Or Service Code:
AZ13: R&D-OTHER R & D-ADV DEV

USAspending Awards / Financial Assistance

Date:
2018-12-20
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DEVELOPMENT OF ITI-333, A ?-OPIOID RECEPTOR PARTIAL AGONIST AND 5HT2A AND D1 RECEPTOR ANTAGONIST, FOR THE TREATMENT OF OPIOID USE DISORDERS
Obligated Amount:
6166204.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2016-06-01
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DEVELOPMENT OF PDE2 INHIBITORS FOR TREATMENT OF ANXIETY/DEPRESSION IN AUTISM/SCHIZOPHRENIA
Obligated Amount:
348094.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2014-06-26
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
CASEIN KINASE 1 INHIBITORS FOR TREATMENT OF AUTISM
Obligated Amount:
318905.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2011-07-12
Awarding Agency Name:
Department of Defense
Transaction Description:
DEVELOPMENT OF A ROBUST PHOSPHO-PROTEIN INTERACTION MAP USEFUL FOR DIAGNOSIS OF NEURODEGENERATIVE DISEASES
Obligated Amount:
-4254.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2009-04-15
Awarding Agency Name:
Department of Defense
Transaction Description:
MOLECULAR MECHANISMS IN THE CO-MORBIDITY OF DEPRESSION, SCHIZOPHRENIA AND ANXIETY
Obligated Amount:
10423433.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
98566842
Mark:
LYTE THEIR WAY
Status:
SUSPENSION LETTER - MAILED
Mark Type:
SERVICE MARK
Application Filing Date:
2024-05-23
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LYTE THEIR WAY

Goods And Services

For:
Providing medical information, namely, information regarding medical conditions and treatments to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment; providing medical information regarding medi...
International Classes:
044 - Primary Class
Class Status:
Active
Serial Number:
97388283
Mark:
LYTE THEIR WAY
Status:
THIRD EXTENSION - GRANTED
Mark Type:
TRADEMARK
Application Filing Date:
2022-04-29
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LYTE THEIR WAY

Goods And Services

For:
Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
97388270
Mark:
LET IN THE LYTE
Status:
THIRD EXTENSION - GRANTED
Mark Type:
TRADEMARK
Application Filing Date:
2022-04-29
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LET IN THE LYTE

Goods And Services

For:
Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
90154881
Mark:
LYTALINK
Status:
REGISTERED
Mark Type:
SERVICE MARK
Application Filing Date:
2020-09-02
Mark Drawing Type:
Illustration: Drawing or design which also includes word(s)/letter(s)/number(s)
Mark Literal Elements:
LYTALINK

Goods And Services

For:
Business administration of patient pharmaceutical reimbursement programs; Business administration assistance for enrolling patients in pharmaceutical reimbursement programs
First Use:
2020-04-01
International Classes:
035 - Primary Class
Class Status:
Active
Serial Number:
90154837
Mark:
LYTALINK
Status:
REGISTERED
Mark Type:
SERVICE MARK
Application Filing Date:
2020-09-02
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LYTALINK

Goods And Services

For:
Business administration of patient pharmaceutical reimbursement programs; business administration assistance for enrolling patients in pharmaceutical reimbursement programs
First Use:
2020-04-01
International Classes:
035 - Primary Class
Class Status:
Active

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 26 Mar 2025

Sources: New York Secretary of State